Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T70485 |
Exp 063
|
||
Exp 063 is a hybrid compound that possesses both the angiotensin II antagonist activity and the β-blocking activity. EXP 063 also acts as a partial β-agonist. | |||
T70484 |
AD-35
|
||
AD-35 is a neuroprotectant for treating Alzheimer’s diseases by significantly inhibiting the production and release of proinflammatory cytokines TNF-α and IL-1β. |